Expanding $1 Billion Brand Club Fits In J&J Consumer Big Picture
This article was originally published in The Tan Sheet
Executive Summary
J&J consumer sector Chairman Jorge Mesquita says the Tylenol analgesic and cough/cold line is an OTC brand the firm expects to join its $1bn club, which already includes the Neutrogena skin care, Listerine oral care and Johnson's Baby lines.
You may also be interested in...
Tylenol Delivers J&J Relief As Global 'Consumer Staples' Sales Slump
J&J says Tylenol outpaced other analgesics in the first quarter as its OTC franchise grew 1.4% on a reported basis to $1.01 bn. CFO Dominic Caruso said new consumer products will add 2 points of incremental growth to the segment in 2017.
Tylenol Delivers J&J Relief As Global 'Consumer Staples' Sales Slump
J&J says Tylenol outpaced other analgesics in the first quarter as its OTC franchise grew 1.4% on a reported basis to $1.01 bn. CFO Dominic Caruso said new consumer products will add 2 points of incremental growth to the segment in 2017.
Tylenol Relaunch Ads Harken To “Trusted” History
In online video ads for Tylenol, the firm says “for everything we do, we know you do so much more.” CFO Dominic Caruso says the ad campaign will reconnect the brand with consumers.